1-3 of 3
Marijn A. Gillissen
Close
Sort by
Journal Articles

AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses

Marijn A. Gillissen, Martijn Kedde, Greta de Jong, Gemma Moiset, Etsuko Yasuda, Sophie E. Levie, Arjen Q. Bakker, Yvonne B. Claassen, Koen Wagner, Martino Böhne, Paul J. Hensbergen, Dave Speijer, Pauline M. van Helden, Tim Beaumont, Hergen Spits, Mette D. Hazenberg
Journal: Blood
Blood (2018) 131 (1): 131–143.
https://doi.org/10.1182/blood-2017-02-768762
Published: 2018
Includes: Supplemental data
Journal Articles

Tumor Specific Glycosylated CD43 Is a Novel and Highly Specific Target for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Marijn A. Gillissen, MD, Martijn Kedde, PhD, Greta de Jong, MD, Etsuko Yasuda, PhD, Sophie E. Levie, Arjen Q. Bakker, Marie Jose Kersten, MD PhD, Paul Hensbergen, PhD, Tim Beaumont, PhD, Pauline M. van Helden, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1646.
https://doi.org/10.1182/blood.V128.22.1646.1646
Published: 2016
Journal Articles

Unique and Potent Tumor Specific Antibodies in Graft Versus Leukemia Responses

Marijn A. Gillissen, MD, Etsuko Yasuda, PhD, Sophie Levie, Arjen Q Bakker, Martijn Kedde, Yvonne B Claassen, Cynthia Huisman, MD PhD, Hergen Spits, PhD, Tim Beaumont, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3826.
https://doi.org/10.1182/blood.V124.21.3826.3826
Published: 2014